No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Dr. Agarwal's Eye Hospital Ltd. is a specialized medical facility offering a comprehensive range of ophthalmic services. Its extensive offerings span various specialties, encompassing cataract surgery, advanced corneal interventions (including LASIK and SMILE), retina treatment, orbit and oculoplasty, glaucoma management, uvea care, neuro-ophthalmology, pediatric ophthalmology, and strabismus correction, alongside optical dispensing. Beyond patient care, the hospital is committed to ongoing professional development through continuous training and actively participates in research and development initiatives. The company was established in 1957 by Jaiveer Agarwal, Tahira Agarwal, Amar Agarwal, and Athiya Agarwal, and maintains its primary operational base in Chennai, India.
www.dragarwal.comNo one on the platform currently holds DRAGARWQ.BO.
No tracked institution reports a position in DRAGARWQ.BO as of their last filing.
No one on the platform has traded DRAGARWQ.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.2% | 12.1% | 12.8% | — | — | — |
| Rev. Growth % | 18.6% | 27.5% | ||||
| Profit Margin % | 14.9% | 13.8% | 9.2% | |||
| Free Cash Flow Margin % | 9.7% | 3.5% | 5.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.5B | +22.3% | $7.51 | $7.51–$7.51 | — | 1 |
| 2028 | $1.6B | +8.0% | $9.72 | $9.72–$9.72 | — | 1 |
| 2029 | $1.8B | +12.1% | $28.26 | $28.26–$28.26 | — | 1 |
| 2030 | $2.0B | +10.0% | $33.68 | $33.68–$33.68 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-12 | $6.03 | $35.76 | +493.0% |
| 2025-10-30 | $6.03 | $41.04 | +580.6% |
| 2025-08-12 | $6.03 | $36.72 | +509.0% |
| 2025-05-28 | $6.03 | $34.02 | +464.2% |
| 2025-02-14 | $6.03 | $22.13 | +267.0% |
| 2024-10-29 | $6.03 | $30.11 | +399.3% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| DRAGARWQ.BODr. Agarwal's Eye Hospital Limited | $5278.65 | +2.77% | $25.5B | — |
| INDOCO.BOIndoco Remedies Limited | $253.80 | +4.85% | $23.3B | — |
| INDOCO.NSIndoco Remedies Limited | $254.00 | +5.22% | $23.4B | — |
| KRSNAA.BOKrsnaa Diagnostics Limited | $536.75 | -0.85% | $17.4B | — |
| KRSNAA.NSKrsnaa Diagnostics Limited |
| $536.40 |
| -0.97% |
| $17.4B |
| — |
| MOREPENLAB.BOMorepen Laboratories Limited | $114.60 | +7.86% | $62.8B | — |
| MOREPENLAB.NSMorepen Laboratories Limited | $114.73 | +8.01% | $62.9B | — |
Source: Financial Modeling Prep · peers by sector/industry